awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37738239-06804BC5-22AA-46CC-AA4E-3F77F4D5C60F
Q37738239-06804BC5-22AA-46CC-AA4E-3F77F4D5C60F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37738239-06804BC5-22AA-46CC-AA4E-3F77F4D5C60F
Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer
P2860
Q37738239-06804BC5-22AA-46CC-AA4E-3F77F4D5C60F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37738239-06804BC5-22AA-46CC-AA4E-3F77F4D5C60F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e42f6e1e0a183b34086b65bdaf6f0a07871350f5
P2860
The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.